Pliant Therapeutics, Inc. (PLRX)
NASDAQ · Manufacturing · Pharmaceutical preparations
$1.08−$0.0600 (−5.26%) on the dayAs of the close; data may be delayed.
PLRX price, last 12 months
Key stats
- Previous close
- $1.14
- Open
- $1.14
- Day range
- $1.08 – $1.14
- 52-week range
- $1.02 – $1.95
- Volume
- 443.7K
- Avg volume (20 days)
- 405.9K
- Market cap
- $66.9M
Performance
1W−2.7%
1M−6.9%
3M−5.3%
6M−12.2%
YTD−11.5%
1Y−26.0%
vs S&P 500, 1Y−42.8 pts
Technicals and fundamentals
About Pliant Therapeutics, Inc.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
- Sector
- Manufacturing
- Industry
- Pharmaceutical preparations
- Listed on
- NASDAQ
- Market cap
- $66.9M